718-1150

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
718 (USA) · Dr. Nolan
consented 2013-01-19

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-03-15 (study day 56.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-16 (study day 149.0); relationship: PROBABLE

mild assessed

Mild BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-16 (study day 29.0); relationship: POSSIBLE

mild assessed

Mild BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-02-16 (study day 29.0); relationship: POSSIBLE

mild assessed

Mild BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-10 (study day 112.0); relationship: POSSIBLE

mild assessed

Mild BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-05-10 (study day 112.0); relationship: POSSIBLE

mild assessed

Mild FOOD CRAVING — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-09 (study day 142.0); relationship: POSSIBLE

mild assessed

Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-31 (study day 194.0); relationship: POSSIBLE

moderate assessed

Moderate UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-06 (study day 47.0); relationship: NONE

moderate assessed

Moderate UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2013-03-06 (study day 47.0); relationship: NONE

Data queries

No data queries.